Clinical Trial Update: Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing capecitabine/irinotecan plus cetuximab to capecitabine/oxaliplatin plus cetuximab in patients with metastatic colorectal cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED